Medical brain–machine interface developer Weiling Medical has closed a financing
round of more than RMB100 million led by Junzhong Capital, with Innotech as the
fund’s core industrial investor. Proceeds will be used to advance clinical
validation of implantable BMI core products, speed medical-device registration,
expand manufacturing capacity and broaden clinical applications in
neurofunctional rehabilitation.